BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23178646)

  • 1. Iron status in patients with chronic heart failure.
    Jankowska EA; Malyszko J; Ardehali H; Koc-Zorawska E; Banasiak W; von Haehling S; Macdougall IC; Weiss G; McMurray JJ; Anker SD; Gheorghiade M; Ponikowski P
    Eur Heart J; 2013 Mar; 34(11):827-34. PubMed ID: 23178646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of Iron Metabolism and Outcomes in Patients with Heart Failure: A Systematic Review.
    Dhaliwal S; Kalogeropoulos AP
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Hepcidin Is Part of a Complex Relation That Links Mortality with Iron Homeostasis and Anemia in Men and Women with HIV Infection.
    Minchella PA; Armitage AE; Darboe B; Jallow MW; Drakesmith H; Jaye A; Prentice AM; McDermid JM
    J Nutr; 2015 Jun; 145(6):1194-201. PubMed ID: 25904736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world experience of intravenous iron sucrose supplementation and dynamics of soluble transferrin receptor and hepcidin in a Spanish cohort of absolute iron deficient patients.
    Tarancon-Diez L; Iriarte-Gahete M; Sanchez-Mingo P; Perez-Cabeza G; Romero-Candau F; Pacheco YM; Leal M; Muñoz-Fernández MÁ
    Biomed Pharmacother; 2023 Nov; 167():115510. PubMed ID: 37757490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients.
    Belo L; Rocha S; Valente MJ; Coimbra S; Catarino C; Bronze-da-Rocha E; Rocha-Pereira P; do Sameiro-Faria M; Oliveira JG; Madureira J; Fernandes JC; Miranda V; Santos-Silva A
    Ren Fail; 2019 Nov; 41(1):662-672. PubMed ID: 31296086
    [No Abstract]   [Full Text] [Related]  

  • 6. Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights.
    Rhodes CJ; Howard LS; Busbridge M; Ashby D; Kondili E; Gibbs JS; Wharton J; Wilkins MR
    J Am Coll Cardiol; 2011 Jul; 58(3):300-9. PubMed ID: 21737024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure.
    Graham FJ; Pellicori P; Masini G; Cuthbert JJ; Clark AL; Cleland JGF
    ESC Heart Fail; 2023 Oct; 10(5):2826-2836. PubMed ID: 37400990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of iron supplementation on serum hepcidin and serum erythropoietin in low-birth-weight infants.
    Berglund S; Lönnerdal B; Westrup B; Domellöf M
    Am J Clin Nutr; 2011 Dec; 94(6):1553-61. PubMed ID: 22071701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imbalance of Iron Availability and Demand in Patients With Acute and Chronic Heart Failure.
    Lanser L; Poelzl G; Messner M; Ungericht M; Zaruba MM; Hirsch J; Hechenberger S; Obersteiner S; Koller B; Ulmer H; Weiss G
    J Am Heart Assoc; 2024 May; 13(9):e032540. PubMed ID: 38639356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron deficiency is an independent risk factor of increased myocardial energy expenditure in chronic heart failure patients.
    Lin F; Huang Y; An D; Zhan Q; Wang P; Lai W; Zeng Q; Dong S; Ren H; Xu D
    Ann Palliat Med; 2021 Dec; 10(12):12061-12071. PubMed ID: 35016401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepcidin and other indicators of iron status, by alpha-1 acid glycoprotein levels, in a cohort of Mexican infants.
    Mendoza E; Duque X; Moran S; Martínez-Andrade G; Reyes-Maldonado E; Flores-Huerta S; Martinez H
    Ann Hematol; 2021 Apr; 100(4):879-890. PubMed ID: 33515046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron Status and Homeostasis Across 2 Competitive Seasons in NCAA Division I Collegiate Cross-Country Runners Residing at Low Altitude.
    Goodrich JA; Frisco DJ; Kim S; VanBaak K; Holliday M; Rueda M; Poddar S; Byrnes WC
    Int J Sports Physiol Perform; 2022 Dec; 17(12):1716-1724. PubMed ID: 36343619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
    Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
    Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Criteria for Iron Deficiency in Patients With Heart Failure.
    Masini G; Graham FJ; Pellicori P; Cleland JGF; Cuthbert JJ; Kazmi S; Inciardi RM; Clark AL
    J Am Coll Cardiol; 2022 Feb; 79(4):341-351. PubMed ID: 35086656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin-25 vs. conventional clinical biomarkers in the diagnosis of functional iron deficiency.
    Enko D; Wagner H; Kriegshäuser G; Kimbacher C; Stolba R; Worf E; Halwachs-Baumann G
    Eur J Haematol; 2015 Dec; 95(6):507-13. PubMed ID: 25598480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery.
    Tussing-Humphreys LM; Nemeth E; Fantuzzi G; Freels S; Holterman AX; Galvani C; Ayloo S; Vitello J; Braunschweig C
    Obesity (Silver Spring); 2010 Oct; 18(10):2010-6. PubMed ID: 20075851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF.
    Docherty KF; Welsh P; Verma S; De Boer RA; O'Meara E; Bengtsson O; Køber L; Kosiborod MN; Hammarstedt A; Langkilde AM; Lindholm D; Little DJ; Sjöstrand M; Martinez FA; Ponikowski P; Sabatine MS; Morrow DA; Schou M; Solomon SD; Sattar N; Jhund PS; McMurray JJV;
    Circulation; 2022 Sep; 146(13):980-994. PubMed ID: 35971840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepcidin and iron deficiency in pre-kidney transplant patients.
    Sancho A; Pastor MC; Troya M; Bonal J; Bayés B; Morales-Indiano C; Lauzurica R; Romero R
    Transplant Proc; 2009; 41(6):2079-81. PubMed ID: 19715836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum hepcidin in haemodialysis patients: associations with iron status and microinflammation.
    Xu Y; Ding XQ; Zou JZ; Liu ZH; Jiang SH; Chen YM
    J Int Med Res; 2011; 39(5):1961-7. PubMed ID: 22118000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality.
    Sierpinski R; Josiak K; Suchocki T; Wojtas-Polc K; Mazur G; Butrym A; Rozentryt P; van der Meer P; Comin-Colet J; von Haehling S; Kosmala W; Przewlocka-Kosmala M; Banasiak W; Nowak J; Voors AA; Anker SD; Cleland JGF; Ponikowski P; Jankowska EA
    Eur J Heart Fail; 2021 Jun; 23(6):919-932. PubMed ID: 33111457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.